Choosing More Than Software

Rather than evaluating isolated features, organizations should assess how well a platform supports their overall manufacturing strategy. Who this matters to:

• Operations: Execution consistency and scalability
• Quality: Data integrity and inspection readiness
• IT: Architecture, integration and lifecycle management

Start with Architecture 

Architecture sets the foundation for success. A modular approach allows manufacturers to deploy required capabilities today while retaining flexibility to expand over time.

Scalability across lines and sites, along with support for on‑premises, cloud or hybrid deployments, enables the platform to evolve alongside business demands and regulatory requirements.

Core Execution Capabilities

At its core, a manufacturing operations platform must support reliable production execution. Key capabilities typically include:

• Electronic batch records (eBR)
• Recipe and workflow management
• Material tracking and weigh-and-dispense
• Comprehensive execution history

These capabilities help standardize production, reduce manual documentation and support traceability across the manufacturing lifecycle.

Integration Readiness

Manufacturing environments are inherently interconnected. MES platforms must integrate with enterprise systems such as ERP and LIMS, as well as automation systems including DCS and PLCs.

Pre‑built connectivity and strong interoperability reduce integration complexity and help avoid fragmented, multi-vendor architectures that increase maintenance and risk.

Data Historians as a Foundation for Insight

A comprehensive data historian is essential for turning raw production data into insight. By combining batch and time‑series data, historians provide a complete view of both discrete and continuous processes.

This historical context enables advanced trending, comparison of production runs and more efficient investigations. Engineers and quality teams can move beyond what happened to understanding why it happened. 

Data, Visibility and Compliance

When execution data, visualization and historical context are unified, manufacturers can move from reactive performance management to proactive improvement. Operational intelligence supports faster root cause analysis, more informed collaboration across teams and continuous process refinement without compromising compliance.

OEE remains a useful indicator, but it is only the starting point. Operational intelligence is what turns performance data into sustained improvement.

Evaluating Total Cost of Ownership

Total cost of ownership extends beyond initial software licensing or implementation costs. Manufacturers should consider long-term system scalability, integration maintenance, vendor dependencies and operational support requirements.

Unified platforms that consolidate execution, data management and visibility can reduce system complexity and simplify ongoing operations. 

A Foundation for Digital Manufacturing

The right MES or manufacturing operations platform becomes part of the manufacturing itself. When selected thoughtfully, it supports connected operations, improved insight and continuous improvement across the production lifecycle.

This completes the series – from understanding MES as a foundation, to unlocking operational intelligence, to selecting a platform that enables both today’s requirements and tomorrow’s manufacturing goals.

Speak with our specialist and see TrackWise Manufacturing in action.

The post How to Choose the Right MES or Manufacturing Operations Platform appeared first on Honeywell.

OEE Is a Starting Point, Not the Destination

In complex, regulated environments, improving performance requires more than retrospective metrics. It requires operational intelligence: the ability to interpret production conditions as they occur and respond before issues escalate.

Who this matters to:

• Operations: Faster response to deviations
• Engineering: Better root cause analysis
• Quality: Improved contextual understanding of events

What OEE Tells You – and What it Doesn’t 

OEE combines three key factors: 

• Availability
• Performance
• Quality

Together, these metrics provide a high-level view of how effectively equipment is being utilized. However, OEE is typically a lagging indicator, meaning it reflects performance after events have already occurred.

While valuable for measuring overall effectiveness, OEE alone does not provide full context around process conditions, material variability, or operator actions that may influence production outcomes. As a result, teams may understand that performance has changed, but additional operational insight is often required to determine why.

Why Operational Intelligence Matters

Pharmaceutical manufacturing generates large volumes of operational data across control systems, execution systems and batch records. When this information remains fragmented, teams struggle to interpret events in real-time.

Operational intelligence focuses on connecting these data sources to provide contextual visibility. Instead of isolated metrics, teams gain a coherent view of what is happening across equipment, processes and batches as production unfolds.

The Role of Real‑Time Process Visualization

Operational intelligence begins with visibility. Unified HMI/SCADA visualization allows operators and engineers to monitor equipment status, alarms, process variables and production progress in real-time.

A consistent visualization layer reduces operational complexity and improves situational awareness. When deviations occur, teams can identify and respond more quickly, rather than waiting for post-batch analysis.

Data Historians as a Foundation for Insight

A comprehensive data historian is essential for turning raw production data into insight. By combining batch and time‑series data, historians provide a complete view of both discrete and continuous processes.

This historical context enables advanced trending, comparison of production runs and more efficient investigations. Engineers and quality teams can move beyond what happened to understanding why it happened. 

From Reporting to Action

When execution data, visualization and historical context are unified, manufacturers can move from reactive performance management to proactive improvement. Operational intelligence supports faster root cause analysis, more informed collaboration across teams and continuous process refinement without compromising compliance.

OEE remains a useful indicator, but it is only the starting point. Operational intelligence is what turns performance data into sustained improvement.

In the final blog of this series, we explore how to evaluate and select an MES or manufacturing operations platform capable of supporting this level of insight and scalability.

Learn how operational intelligence builds on MES execution data

The post Improving Manufacturing Performance – Moving Beyond OEE to Operational Intelligence appeared first on Honeywell.

Why MES Matters More Than Ever in Life Sciences?

Manufacturing Execution Systems (MES) have become essential infrastructure in this context. They provide the real-time execution layer that connects people, processes and data across the shop floor, enabling traceability, consistency and regulatory compliance.

Who this matters to:

• Operations: Consistent execution across shifts and sites
• Quality: Reliable, inspection-ready records
• IT: A scalable execution layer that integrates cleanly with enterprise systems

What an MES Does in Practice?

An MES sits between enterprise systems such as ERP and the shop-floor control layer, including HMI/SCADA and automation systems. While ERP focuses on planning and business transactions, MES manages how production is actually executed. 

In practical terms, MES coordinates materials, equipment and operators as production progresses. It captures process parameters, equipment states and operator actions at the moment work is performed, creating a structured, electronic record of manufacturing activities. This execution-level visibility is critical in pharmaceutical manufacturing, where complete and accurate documentation is mandatory.

A key outcome of MES is the creation of an “as-built” manufacturing record. Instead of reconstructing events after a batch is complete, MES records production history in real-time. This improves transparency during manufacturing and provides a reliable foundation for batch review, investigations and inspections.

Why Legacy Manufacturing Systems Fall Short?

Many life sciences manufacturers still rely on a combination of disconnected control systems, spreadsheets and manual data entry. Production data may be split across multiple sources: equipment events in automation systems, batch records in paper or PDFs and operator actions in logbooks. 

This limits visibility, slows decision‑making and increases data integrity risk. Manual transcription can introduce errors and delays, particularly during batch review and release. As production volumes and product complexity grow, these approaches become increasingly difficult to scale.

Core Capabilities of a Modern MES

A modern MES unified execution, data capture and visibility in a single environment. Core capabilities typically include:

Batch Management & Execution: MES coordinates and controls the execution of production batches based on predefined manufacturing instructions. This helps support consistent execution of approved workflows across production batches.

Recipe Authoring & Control: Digital recipe management allows manufacturers to define process parameters and instructions within a controlled environment. Once approved, these recipes guide operators through each step of the manufacturing process.

Material Tracking: MES provides full traceability of materials used during production. Raw materials, intermediates and finished products can be tracked throughout the manufacturing process, supporting product genealogy and traceability requirements.

Electronic Batch Records (eBR): Electronic batch records replace traditional paper documentation by capturing manufacturing data automatically during production. This reduces manual data entry, improves accuracy and accelerates batch review processes.

OEE Integration: Many MES platforms integrate Overall Equipment Effectiveness (OEE) monitoring to measure equipment availability, performance and quality. These insights help manufacturers identify bottlenecks, reduce downtime and continuously improve operational efficiency.

Together, these capabilities reduce manual effort, support consistent execution of approved procedures and provide a reliable data foundation for continuous improvement. 

Supporting Regulatory Compliance

Regulatory compliance is foundational in pharmaceutical manufacturing and MES plays a central role in supporting it. Modern MES platforms include built‑in audit trails, secure electronic records and system controls designed to support regulatory requirements such as 21 CFR Part 11.

By capturing data directly at the point of execution and maintaining complete, timestamped records, MES strengthens data integrity and simplifies inspection readiness. Rather than assembling documentation retrospectively, quality teams can review structured electronic records that reflect exactly how production occurred. 

The Business Impact of MES

Beyond compliance, MES delivers tangible business value. Manufacturers benefit from improved traceability, reduced batch release timelines and greater operational agility. Most importantly, MES provides a scalable digital foundation that supports long-term manufacturing transformation without adding any unnecessary system complexity.

MES is no longer optional in pharmaceutical manufacturing. It is essential infrastructure.

In the next blog, we look beyond execution and explore how manufacturers use this data foundation to move from basic performance metrics toward operational intelligence. 

Explore how MES fits into a modern pharmaceutical architecture.

The post What is MES in Pharma Manufacturing? A Practical Guide appeared first on Honeywell.

For leaders responsible for quality and manufacturing operations in regulated life sciences environments, the challenge today isn’t a lack of data.  It’s achieving real-time visibility, connected intelligence and timely intervention to protect patients, maintain compliance and safeguard business continuity.

What you’ll learn in this article:

• Why traditional, retrospective quality oversight no longer meets the needs of modern life sciences manufacturing operations
• How connected systems improve visibility across quality, manufacturing, supply chain and post-market activities
• The role AI plays in strengthening – not replacing – human decision-making in regulated environments
• Why early signal detection and end-to-end traceability are critical to recall readiness and compliance confidence
• How quality and manufacturing leaders can shift from reactive control to proactive risk management 

The shift life sciences operations leaders need to make now

For years, quality operations in life sciences manufacturing have focused on documentation. Teams recorded what happened, proved compliance and explained decisions later. That still matters, but it’s no longer enough.

In modern life sciences quality and manufacturing operations, the goal is real-time quality management — not retrospective documentation. Documentation shows what happened. Active management helps you change what happens next.

Why real-time signals matter in regulated manufacturing environments

Traditional oversight relied on periodic checks. Batch records were reviewed after completion and trends were analyzed retrospectively. That approach worked when data was slow and manual. 

Today, the life sciences manufacturing shop floor generates constant signals – from processes, equipment, environments and people. The goal isn’t to watch everything. It’s to surface the right signals early enough for teams to intervene while there’s still time to make a difference. When you can see risk forming, not just risk realized, quality shifts from reactive control to proactive protection. 

Navigate complexity with connected systems

Most quality and compliance breakdowns occur when critical systems operate in silos. Manufacturing, quality, supply chain and post-market data often live in separate places, forcing teams to stitch context together by hand. That slows decisions and increases uncertainty – especially when time matters most.

With connected systems, you can navigate complexity more easily. Issues show up in context. Investigations start with insight instead of guesswork, and teams spend less time chasing information and more time making informed decisions.

AI that accelerates decisions – not replaces them 

AI can scan large volumes of data, spot subtle patterns and flag anomalies faster than any human could. What it shouldn’t do is make accountability-heavy decisions on its own.

Used the right way, AI helps your team focus attention where it matters most. It connects the dots; highlights risks and brings evidence forward. Your experts still make the call – just faster, with more confidence and a clearer audit trail. That’s how AI strengthens decision-making without compromising responsibility. 

Build recall readiness into daily operations

Recall readiness doesn’t start when a recall is triggered. It starts with end-to-end traceability built into everyday work.

When materials, manufacturing conditions, quality events and distribution data are connected, your team can scope issues accurately, understand root causes faster and avoid overly broad responses driven by uncertainty. That precision protects people – and limits unnecessary disruption to your business. 

Detect issues early to minimize compliance and supply chain impact

Every delayed signal increases risk. The longer an issue stays hidden, the more product moves forward and the harder it becomes to intervene cleanly.

Early detection lets you connect processes before defects spread, contain issues before distribution and resolve concerns without formal escalation. It’s not just about efficiency, it’s about trust with customers, regulators and partners.

How to lead differently now

If you’re looking to strengthen quality decision-making, start here:

• Make signals your priority: Ask your team what they can see in real-time that would let them intervene sooner – not weeks later
• Reduce handoffs: Treat manufacturing, quality and post-market data as one connected picture, not separate workflows
• Use AI to focus attention: Let it triage, correlate and surface risk – while people stay accountable for decisions
• Strengthen traceability every day: Don’t wait for a recall to test whether you can trace impacted product precisely 
• Measure leading indicators: Track time-to-signal, time-to-intervention and how often issues are prevented before release
• Change the conversation: Shift meetings from status updates to risk reviews and decisions that need to be made now 

A more confident way forward

The future of quality won’t be defined by a single platform or technology. It will be shaped by how leaders think about data, accountability and action.

Organizations that succeed will use real-time signals as strategic assets, connect intelligence across operations, apply AI to sharpen judgment and act early to protect both people and the business. 

Quality isn’t just about documenting what happened. Modern quality leadership is defined by connected data, AI-augmented decision-making and proactive risk management: enabling organizations to act with speed, precision and regulatory confidence.

Speak with our Life Sciences experts to explore how connected systems and AI can strengthen your quality operations: Connect Now

The post Rethinking Life Sciences Quality & Manufacturing Operations in the Age of AI And Connected Systems appeared first on Honeywell.

The problem? Paper introduces delays, errors, and compliance risks that can directly impact product quality and time to market. That’s why more life sciences companies are shifting toward digital procedures and electronic logbooks: two pillars of a modern manufacturing execution strategy that deliver speed, traceability, and quality without compromise. 

Why the Life Sciences Industry is Moving Beyond Paper

Life Sciences companies operate under strict guidelines like FDA 21 CFR Part 11, EU Annex 11, and PIC/S GMP requirements. While paper records may meet compliance needs on the surface, they often fail in practice. Physical logbooks can be misplaced, and illegible handwriting often results in unstructured data that makes periodic analysis difficult- whether by keyword searches or by specific parameters. Retrieving and contextualizing data for an audit can take weeks or even months, delaying responses to regulators and slowing investigations.

Industry drivers for change include: 

• Regulatory expectations for real-time traceability: Agencies increasingly expect immediate access to historical records and process deviations. Digital tools allow instant search and retrieval.
• Globalized supply chains: With manufacturing and quality operations often spread across multiple sites and countries, paper workflows create bottlenecks in data sharing. 
• Growing complexity of processes: As therapies become more specialized, such as biologics and cell & gene therapies, the number of process parameters and associated documentation increases exponentially.

According to an article by McKinsey, accuracy is only 91% when documentation tasks are done manually. ¹ 

Digital Procedures: Making Every Step Count

Digital procedures replace static paper SOPs and work instructions with interactive, step-by-step digital workflows that guide operators through complex manufacturing tasks. Instead of flipping through binders, operators use tablets or shop-floor workstations to view instructions, input data, capture measurements, and confirm completion in real time. 

The Business Case for Digital Procedures 

Digital procedures go beyond compliance. They provide organizations with the ability to streamline execution, reduce bottlenecks, and maintain consistency across global operations. By replacing static paper-based instructions with real-time, guided digital workflows, manufacturers unlock efficiency gains while lowering risk and error rates. The value can be viewed in three dimensions: 

1. Beyond compliance, towards operational excellence: Digital procedures not only ensure each step is executed according to regulatory standards but also make it easier to adapt when those standards are refined or redefined. At the same time, they enable organizations to measure adherence and spot process deviations instantly.
2. Faster cycle times: Paper-based instructions require manual updates, distribution, and verification. Digital procedures push updates instantly across all sites, ensuring operators are always working with the latest version.  
3. Error reduction and data integrity: Human error such as skipped steps or missed signatures, is a major source of deviations. Digital workflows enforce step completion before progression, minimizing the risk of overlooked tasks. Built-in data validation checks ensure entries are complete, accurate, and consistent. 

Best Practices for Implementing Digital Procedures 

1. Involve end users early: Operators should help design workflows to ensure usability and practicality. 
2. Integrate with existing systems: Linking digital procedures with MES, QMS, or ERP ensures that data flows seamlessly into broader quality and planning processes. 
3. Enable multimedia support: Images, diagrams or video clips can clarify complex steps far better than text alone. 

eLogbooks: The Digital Memory of Manufacturing

If digital procedures guide the how, e-logbooks capture the what and when of manufacturing. These electronic records replace physical logbooks for equipment use, cleaning, calibration, environmental monitoring, and other critical activities. 

Why eLogbooks are a Natural Next Step 

Traditional logbooks depend on timely, legible entries and physical storage. In reality, entries may be delayed until the end of a shift, handwriting can be unclear, and archived logs may be stored off-site. E-logbooks remove these pain points entirely. 

Key benefits include: 

• Real-time, centralized access: Any authorized user can view the latest log entries from any location, improving oversight and collaboration. 
• Audit readiness: Digital time stamping and electronic signatures make demonstrating compliance faster and easier. 
• Trend analysis: Structured, searchable data enables better preventive maintenance planning and root-cause analysis. 

From Compliance Tool to Continuous Improvement Driver 

While e-logbooks are often adopted to satisfy data integrity regulations, their long-term value lies in driving process optimization. Aggregating log data across equipment and shifts can reveal patterns that paper records simply can’t, including:

• Identifying recurring maintenance needs on specific machines. 
• Tracking cleaning cycle durations to optimize changeover times. 
• Linking environmental conditions to product quality outcomes. 

Implementing eLogbooks Successfully 

1. Start with high-impact areas: Focus on logs that are most frequently accessed or prone to errors. 
2. Ensure 21 CFR Part 11 compliance: Audit trails, user authentication, and electronic signatures are non-negotiable. 
3. Integrate with digital procedures: Operators should be able to log data within the same workflow they follow for task execution. 

Digital Procedures + eLogbooks: Better Together 

The true value emerges when digital procedures and e-logbooks are connected in a unified system. For example, completing a digital cleaning procedure can automatically update the corresponding equipment log—removing duplicate data entry and reducing the risk of inconsistencies. 

This integration offers: 

• Single source of truth: Operators, quality teams, and auditors all work from the same validated records. 
• Faster release cycles: Linked systems make it easier to verify that all necessary steps and records are complete. 
• Improved cross-site standardization: Procedures and logs follow the same formats across global facilities. 

Pharma manufacturing can no longer afford the inefficiencies of paper-based records. Digital procedures and e-logbooks deliver the compliance, efficiency, and data integrity that modern operations demand—while providing a foundation for continuous improvement and innovation. 

As the industry continues to face pressure to bring therapies to market faster without compromising quality, and under mounting regulatory scrutiny where non-compliance risks credibility, revenue, and reputation- the adoption of these digital tools is no longer a question of if, but when!

Explore how TrackWise Manufacturing eLogbooks can streamline your operations: Download datasheet | Schedule a demo.

Sources:  

¹ McKinsey, Operations can launch the next blockbuster in pharma, Feb.16, 2021 

The post From Paper to Performance: How Digital Procedures and eLogbooks are Transforming Pharma Manufacturing appeared first on Honeywell.